About us
About us
Our company
Culture
Chairman message
History
IP Strategy
Honors
Presence
Partner
Technology Platforms
Technology Platforms
Core Technology
Therapeutic Area
R&D system
Facilities
Products
Products
New Drug for licensing out
505B(2)
Generic Drug
Service
News
News
Contact
Contact
Company News
Industry Reports
Select year
2020
2021
2022
2022-11-30
A tRNA-derived fragment from Chinese yew suppresses ovarian cancer growth via targeting TRPA1: Molecular Therapy - Nucleic Acids
Full text
2022-08-08
PolyU collaborates with Increasepharm (HK) Limited for CM-based new drug development
Full text
2022-08-08
Reviewer Guidance for Nebulizers, Metered Dose Inhalers, Spacers and Actuators
Full text
2021-08-08
Hydrogen Peroxide Nebulization and COVID Resolution
Full text
2021-08-08
In situ gel-forming system: an attractive alternative for nasal drug delivery
Full text
2020-08-08
Research and Application of In-situ Gel Preparation
Full text